John Powers and Cheryl Coon discuss framing COA endpoints, emphasizing the importance of protocol clarity, treatment benefits, evidence, and patient-centric analysis. They also explore the complexities of specifying endpoints, the balance between specificity and broadness, and the innovative approach to developing outcome measures in clinical trials.